.png)
Agenzia Italiana del Farmaco
home
Highlights
-
29 Jul 2025
Press releases
IThe AIFA Board of Directors approves the reimbursability of 11 medicines, including the first gene therapy for haemophilia B
The National Health Service will reimburse the first one-shot treatment for severe and moderately severe haemophilia B, a rare and potentially fatal disease that causes bleeding in the joints, muscles and internal organs.
-
25 Jul 2025
Press releases
AIFA 2025 call for proposals for independent research on rare diseases: 100 projects submitted, for a total funding of €17.8 million
“The first AIFA call for proposals dedicated exclusively to rare diseases closed with a round figure: 100 projects represent a great result, which testifies to the vitality and high level of Italian research, which responded with great interest,” emphasises Robert Nisticò, president of the Italian Medicines Agency.
-
07 Aug 2025
AIFA Notes
Revision of AIFA Notes: repeal of Notes 2, 4 and 41
As of 7 August 2025, AIFA Notes 2, 4 and 41 are repealed.
-
30 Jul 2025
Press releases
AIFA monitoring of final data for January-December 2024
Pharmaceutical expenditure for direct purchases by the Regions exceeds the budget by 4 billion.
-
29 Jul 2025
Press releases
IThe AIFA Board of Directors approves the reimbursability of 11 medicines, including the first gene therapy for haemophilia B
The National Health Service will reimburse the first one-shot treatment for severe and moderately severe haemophilia B, a rare and potentially fatal disease that causes bleeding in the joints, muscles and internal organs.
-
25 Jul 2025
Press releases
AIFA 2025 call for proposals for independent research on rare diseases: 100 projects submitted, for a total funding of €17.8 million
“The first AIFA call for proposals dedicated exclusively to rare diseases closed with a round figure: 100 projects represent a great result, which testifies to the vitality and high level of Italian research, which responded with great interest,” emphasises Robert Nisticò, president of the Italian Medicines Agency.
-
07 Aug 2025
AIFA Notes
Revision of AIFA Notes: repeal of Notes 2, 4 and 41
As of 7 August 2025, AIFA Notes 2, 4 and 41 are repealed.
-
30 Jul 2025
Press releases
AIFA monitoring of final data for January-December 2024
Pharmaceutical expenditure for direct purchases by the Regions exceeds the budget by 4 billion.
News
22 Aug 2025
Medicine shortages
Direct communication with healthcare professionals on supply shortage Zypadhera
21 Aug 2025
Quality and Inspections
Direct communication with healthcare professionals on Evrysdi
01 Aug 2025
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
30 Jul 2025
Monitoring pharmaceutical expenditure
Monitoring of Pharmaceutical expenditure - January / December 2024 (Final balance)
30 Jul 2025
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 17 February 2025
23 Jul 2025
Monitoring Registers
Hepatitis C: update of 21 July 2025 concerning enrolled patients
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
